Treats megaloblastic anemias due to folic acid deficiency. ANDA 89384, held by Hikma. Leucovorin Calcium.
As of Nov 16, 2026, ANDA 89384 (Leucovorin Calcium), held by Hikma, was first approved by FDA on Sep 14, 1987, with 16 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Leucovorin Calcium, USP rescue is indicated after high dose methotrexate therapy in osteosarcoma. Leucovorin Calcium, USP is also indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosages of folic acid antagonists. Leucovorin Calcium, USP is indicated in the treatment of megaloblastic anemias due to folic acid deficiency when oral therapy is not feasible. Leucovorin Calcium, USP is also indicated for use in combination with 5-fluorouracil to prolong survival in the palliative treatment of patients with advanced colorectal cancer.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 14, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Leucovorin CalciumEQ 50MG BASE/VIAL · injectable;injection | Leucovorin Calcium | Rx |
| Oct 13, 2020 | Supplement 31Labeling · Standard review | Approved | None posted |
| Jan 17, 2012 | Supplement 22Labeling | Approved | |
| May 30, 2001 | Supplement 14Manufacturing | Approved | None posted |
| May 30, 2001 | Supplement 13Manufacturing | Approved | None posted |
| May 30, 2001 | Supplement 12Manufacturing | Approved | None posted |
| Dec 4, 2000 | Supplement 11Manufacturing | Approved | None posted |
| Aug 3, 1998 | Supplement 10Labeling | Approved | None posted |
| Feb 24, 1998 | Supplement 9Labeling | Approved | None posted |
| May 31, 1996 | Supplement 8Labeling | Approved | None posted |
| Sep 25, 1995 | Supplement 7Manufacturing | Approved | None posted |
| Aug 8, 1995 | Supplement 2Manufacturing | Approved | None posted |
| Mar 21, 1994 | Supplement 6Manufacturing | Approved | None posted |
| Jun 2, 1993 | Supplement 5Labeling | Approved | None posted |
| Sep 2, 1992 | Supplement 4Manufacturing | Approved | None posted |
| Sep 2, 1992 | Supplement 1Manufacturing | Approved | None posted |
| Mar 11, 1991 | Supplement 3Labeling | Approved | None posted |
| Sep 14, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters